Skip to main content

Table 2 Correlation between the clinicopathological features and expression of miR-216

From: MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis

Patient characteristics

miR-216 expression

P-value

Low

High

Age (years)

≤55

36

40

0.627

>55

39

35

FIGO stage

I, II

10

41

< 0.001

III, IV

65

34

Histology

Squamous

54

67

= 0.012

Others

21

8

Survival status

Alive

9

46

< 0.001

Dead

66

29

  1. Patient number of miR-216b-low and miR-216b-high groups and the corresponding proportion (%) were shown. The clinicopathological differences between miR-216b-low and miR-216b- high groups were analyzed using Pearson’s χ2 test
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us